About Everest Organics Limited

OVERVIEW

Everest Organics Limited (EOL). is an Indian pharmaceutical company based in Hyderabad, Telangana. It was incorporated in February 1993 to manufacture bulk drugs such as Dichloroflurobenzene, Ciprofloxacin, Omeprazole and Benzimadizole. Today, the company manufactures and markets Active Pharmaceutical Ingredients (APIs) and Intermediates to domestic and international markets.

Company Highlights

32-acre manufacturing unit in Andhra Pradesh.
Major export markets include USA, South America, Europe, Far East and Middle East.
Provides Drug Master Files and Common Technical Documents for products.
Product compliance with pharmacopial standards such as BP, USP, EP and IP Standards (or as desired by the customer).

Everest Organics Limited is listed on the Bombay Stock Exchange (BSE).

Everest Organics Limited at-a-glance

Total Revenue (31 March, 2017): USD 16.6 million

?107.88 crores

Employees (31 March, 2017):

361

Manufacturing Facilities:

Major Export Markets:

USA, Europe,

Middle East, Far

East, South

America

Certifications and Approvals

ISO 9001-2008
GMP
Drug Control Authority of Andhra Pradesh

Source:

Company Annual Report

^As per Reserve Bank of India’s Reference Rate for the US Dollar (at ?64.8386) on March 31, 2017

History

Everest Organics Limited was incorporated on 19th February 1993. It was started by Dr. SK Srihari Raju, an NRI doctor with more than two decades of experience in the medical field. Construction of the manufacturing plant in Andhra Pradesh commenced in 1994. In 1995, the company went public, and its shares were over-subscribed by over 39 times. The company started its commercial production in 1996.